This bill requires the Government Accountability Office to study the feasibility of assessing user fees to offset federal costs associated with single-source materials for which the Strategic National Stockpile is the sole provider (e.g., certain antitoxins).
The study must address whether health care providers or other entities that receive such materials generate profits when charging patients for them.